FDA approves 1st new Alzheimer’s drug in nearly two decades against some experts’ advice
| The Food and Drug Administration approved a new drug for Alzheimer’s disease on Monday even though the much-debated treatment has been panned by some experts amid rocky clinical trials.
The Food and Drug Administration (FDA) on Monday granted approval for the first new Alzheimer’s treatment since 2003, greenlighting Biogen’s drug aducanumab. |
